Is GSK or MCK cheaper?

On trailing earnings, GSK is cheaper: GSK trades at a 11.62 P/E and MCK at 19.85.

Which has grown faster, GSK or MCK?

Over the past five years, MCK grew revenue faster — GSK at a 0.63% CAGR versus MCK at 11.11%.

Does GSK or MCK pay a bigger dividend?

GSK yields 3.51% and MCK yields 0.43% based on trailing dividends and the latest price.

Is GSK or MCK more profitable?

GSK runs the higher net margin — GSK at 17.76% versus MCK at 1.18%.

Which has been the better investment, GSK or MCK?

Over the past 10-year, MCK delivered the higher annualized total return — GSK at 7.50% versus MCK at 16.73%. Past performance doesn't predict future results.

GSK plc (GSK) vs McKesson Corporation (MCK)

GSK leads on 10 of 16 compared metrics.

A side-by-side comparison of GSK plc and McKesson Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 27, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

Total return — GSK vs MCK

growth of $100 · last 30y

GSK +98.1%MCK +3112.4%MCK compounded faster

Log scale — wide-divergence pair

GSK MCK

GSK vs MCK: by the numbers

•GSK is the larger company ($105.20B vs $90.28B market cap).
•GSK trades at the lower earnings multiple (11.62 vs 19.85 P/E).
•GSK converts more revenue to profit (17.76% vs 1.18% net margin).
•MCK grew revenue faster over the past five years (11.11% vs 0.63% CAGR).
•GSK pays the higher dividend yield (3.51% vs 0.43%).

Which is better, GSK or MCK?

Metric tally: GSK 10 · MCK 6

It depends on what you're optimizing for:

ValueGSK(lower P/E)

GrowthMCK(faster 5Y revenue CAGR)

IncomeGSK(higher dividend yield)

QualityMCK(higher ROIC)

Metrics side by side

Valuation

Metric	GSK	MCK
P/E ratio	11.62●	19.85
Forward P/E	13.25●	15.16
P/S ratio	2.42	0.23●
P/B ratio	3.44	—
PEG ratio	0.02●	0.46
EV / EBITDA	8.62●	13.85
FCF yield	7.87%●	6.33%

Profitability

Metric	GSK	MCK
Gross margin	72.67%●	3.61%
Operating margin	25.65%●	1.58%
Net margin	17.76%●	1.18%
ROE	25.19%●	-219.24%
ROIC	16.61%	31.48%●

Dividends

Metric	GSK	MCK
Dividend yield	3.51%●	0.43%
Payout ratio	24.30%	8.51%

Growth (annualized)

Metric	GSK	MCK
Revenue CAGR (5Y)	0.63%	11.11%●
EPS CAGR (5Y)	14.05%	40.71%●
FCF CAGR (5Y)	-0.35%	8.76%●
Total return CAGR (5Y)	10.18%	32.85%●

Frequently asked

Which is better, GSK or MCK?: It depends on your goal. value: GSK (lower P/E); growth: MCK (faster 5Y revenue CAGR); income: GSK (higher dividend yield); quality: MCK (higher ROIC). Across all compared metrics, GSK leads 10 to 6.
Is GSK or MCK cheaper?: On trailing earnings, GSK is cheaper: GSK trades at a 11.62 P/E and MCK at 19.85.
Which has grown faster, GSK or MCK?: Over the past five years, MCK grew revenue faster — GSK at a 0.63% CAGR versus MCK at 11.11%.
Does GSK or MCK pay a bigger dividend?: GSK yields 3.51% and MCK yields 0.43% based on trailing dividends and the latest price.
Is GSK or MCK more profitable?: GSK runs the higher net margin — GSK at 17.76% versus MCK at 1.18%.
Which has been the better investment, GSK or MCK?: Over the past 10-year, MCK delivered the higher annualized total return — GSK at 7.50% versus MCK at 16.73%. Past performance doesn't predict future results.

Go deeper

Full GSK analysis Full MCK analysis Interactive comparison tool

Dig into the metrics

GSK P/E ratio McKesson P/E ratio GSK dividend yield McKesson dividend yield GSK ROE McKesson ROE GSK operating margin McKesson operating margin GSK revenue growth McKesson revenue growth GSK free cash flow McKesson free cash flow

GSK & McKesson appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 27, 2026.